Study details
Enrolling now
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
Southern California Institute for Research and Education
NCT IDNCT03073343ClinicalTrials.gov data as of Apr 2026
Target enrollment
48
Study length
about 12 years
Ages
18–75
Locations
1 site in CA
About this study
This trial is testing two different doses of oral betaine to see if it helps with liver problems. Patients will take the betaine as a powder mixed in water and drink it daily for 4431 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.Betaine (trimethyglycine)
DrugBetaine (trimethyglycine)
Routeoral
Primary goalChange in alanine aminotransferase (ALT) level in all study participants
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low14%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
betaine
Drug routes
oral (Oral Tablet)
Endpoints
Primary: Change in alanine aminotransferase (ALT) level in all study participants
Secondary: Compare changes in alanine aminotransferase (ALT) level in both cohorts
Body systems
Endocrinology